Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah R Caswell

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Medicine|July 19, 2017
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcomeDeborah R Caswell, Charles Swanton
Trends in Cell Biology|August 17, 2021
Capturing cancer evolution using genetically engineered mouse models (GEMMs)William Hill, Deborah R Caswell, Charles Swanton
Nature Genetics|September 27, 2023
Tumor heterogeneity impairs immunogenicity in mismatch repair deficient tumorsJames L Reading, Deborah R Caswell, Charles Swanton
Trends in Cancer|February 12, 2026
Lung cancer in never smokers: from early detection to preventionDeborah R Caswell, Crispin Hiley, Cian Murphy, et al.
Molecular Cancer Research : MCR|July 14, 2018
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung AdenocarcinomaDeborah R Caswell, Chen-Hua Chuang, Rosanna K Ma, et al.
Cancer Discovery|April 18, 2014
Obligate progression precedes lung adenocarcinoma disseminationDeborah R Caswell, Chen-Hua Chuang, Dian Yang, et al.
Cancer Cell|May 7, 2016
An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-SufficiencyJennifer J Brady, Chen-Hua Chuang, Peyton G Greenside, et al.
Genes & Development|July 17, 2015
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editingShin-Heng Chiou, Ian P Winters, Jing Wang, et al.
Nature Medicine|February 14, 2017
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axisChen-Hua Chuang, Peyton G Greenside, Zoë N Rogers, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Medicine|July 19, 2017
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcomeDeborah R Caswell, Charles Swanton
Trends in Cell Biology|August 17, 2021
Capturing cancer evolution using genetically engineered mouse models (GEMMs)William Hill, Deborah R Caswell, Charles Swanton
Nature Genetics|September 27, 2023
Tumor heterogeneity impairs immunogenicity in mismatch repair deficient tumorsJames L Reading, Deborah R Caswell, Charles Swanton
Trends in Cancer|February 12, 2026
Lung cancer in never smokers: from early detection to preventionDeborah R Caswell, Crispin Hiley, Cian Murphy, et al.
Molecular Cancer Research : MCR|July 14, 2018
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung AdenocarcinomaDeborah R Caswell, Chen-Hua Chuang, Rosanna K Ma, et al.
Cancer Discovery|April 18, 2014
Obligate progression precedes lung adenocarcinoma disseminationDeborah R Caswell, Chen-Hua Chuang, Dian Yang, et al.
Cancer Cell|May 7, 2016
An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-SufficiencyJennifer J Brady, Chen-Hua Chuang, Peyton G Greenside, et al.
Genes & Development|July 17, 2015
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editingShin-Heng Chiou, Ian P Winters, Jing Wang, et al.
Nature Medicine|February 14, 2017
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axisChen-Hua Chuang, Peyton G Greenside, Zoë N Rogers, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Pageof 2